Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Lønning, Per Eystein; Berge, Elisabet Ognedal; Bjørnslett, Merete Pauline; Minsaas, Laura;
Chrisanthar, Ranjan
; Vetti, Hildegunn Høberg; Dulary, Cécile; Busato, Florence; Bjørneklett, Silje; Eriksen, Christine; Kopperud, Reidun Kristin; Axcrona, Ulrika; Davidson, Ben; Bjørge, Line; Evans, D. Gareth; Howell, Anthony; Salvesen, Helga; Janszky, Imre; Hveem, Kristian; Romundstad, Pål Richard; Vatten, Lars Johan; Tost, Jörg; Dørum, Anne; Knappskog, Stian
(2018).
White blood cell BRCA1 promoter methylation status and ovarian cancer risk.
Annals of Internal Medicine.
Vol. 168.
https://doi.org/10.7326/M17-0101
Yndestad, Synnøve; Austreid, Eilin; Knappskog, Stian;
Chrisanthar, Ranjan
; Lilleng, Peer Kåre; Lønning, Per Eystein; Eikesdal, Hans Petter
(2017).
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.
Breast Cancer Research and Treatment.
Vol. 163.
https://doi.org/10.1007/s10549-017-4160-5
Knappskog, Stian; Berge, Elisabet Ognedal;
Chrisanthar, Ranjan
; Geisler, Stephanie; Staalesen, Vidar; Leirvaag, Beryl; Yndestad, Synnøve; Faveri, Elise Norheim de; Karlsen, Bård Ove; Wedge, David C.; Akslen, Lars A.; Lilleng, Peer Kåre; Løkkevik, Erik; Lundgren, Steinar; Østenstad, Bjørn; Risberg, Terje; Mjaaland, Ingvil; Aas, Turid; Lønning, Per Eystein
(2015).
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Molecular Oncology.
Vol. 9.
https://doi.org/10.1016/j.molonc.2015.04.008
Knappskog, Stian;
Chrisanthar, Ranjan
; Løkkevik, Erik; Anker, Gun Birgitta; Østenstad, Bjørn; Lundgren, Steinar; Risberg, Terje; Mjaaland, Ingvil; Leirvaag, Beryl; Miletic, Hrvoje; Lønning, Per Eystein
(2012).
Low expression levels of ATM may substitute for CHEK2/TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Breast Cancer Research.
Vol. 14.
https://doi.org/10.1186/bcr3147
Chrisanthar, Ranjan
; Knappskog, Stian; Løkkevik, Erik; Anker, Gun Birgitta; Østenstad, Bjørn; Lundgren, Steinar; Risberg, Terje; Mjaaland, Ingvil; Skjønsberg, Gudbrand; Aas, Turid; Schlichting, Ellen; Fjøsne, Hans Erikssønn; Nysted, Arne; Lillehaug, Johan R.; Lønning, Per Eystein
(2011).
Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel.
PLOS ONE.
Vol. 6.
https://doi.org/10.1371/journal.pone.0019249
Knappskog, Stian; Bjørnslett, Merete Pauline; Myklebust, Line Merethe; Huijts, Petra E.A.; Vreeswijk, Maaike P.; Edvardsen, Hege; Guo, Yongli; Zhang, Xuemei; Yang, Ming; Ylisaukko-oja, Sanna K.; Alhopuro, Pia; Arola, Johanna; Tollenaar, Rob A.E.M.; Asperen, Christi J van; Seynaeve, Caroline; Staalesen, Vidar;
Chrisanthar, Ranjan
; Løkkevik, Erik; Salvesen, Helga Birgitte; Evans, D. Gareth; Newman, William G.; Lin, Dongxin; Aaltonen, Lauri; Børresen-Dale, Anne-Lise; Tell, Grethe S; Stoltenberg, Camilla; Romundstad, Pål Richard; Hveem, Kristian; Lillehaug, Johan R.; Vatten, Lars Johan; Devilee, Peter; Dørum, Anne; Lønning, Per Eystein
(2011).
The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians.
Cancer Cell.
Vol. 19.
https://doi.org/10.1016/j.ccr.2010.12.019
Chrisanthar, Ranjan
; Knappskog, Stian; Løkkevik, Erik; Anker, Gun Birgitta; Østenstad, Bjørn; Lundgren, Steinar; Berge, Elisabet Ognedal; Risberg, Terje; Mjaaland, Ingvil; Mæhle, Lovise Olaug; Engebretsen, Lars Fredri; Lillehaug, Johan; Lønning, Per Eystein
(2008).
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
PLOS ONE.
Vol. 3:e0003062.
https://doi.org/10.1371/journal.pone.0003062
Lønning, Per Eystein;
Chrisanthar, Ranjan
; Staalesen, Vidar; Knappskog, Stian; Lillehaug, Johan
(2007).
Adjuvant treatment: the contribution of expression microarrays.
Breast Cancer Research.
Vol. 9.
https://doi.org/10.1186/bcr1812
Lønning, Per Eystein; Knappskog, Stian; Staalesen, Vidar;
Chrisanthar, Ranjan
; Lillehaug, Johan
(2007).
Breast cancer prognostication and prediction in the postgenomic era.
Annals of Oncology.
Vol. 18.
https://doi.org/10.1093/annonc/mdm013
Knappskog, Stian;
Chrisanthar, Ranjan
; Staalesen, Vidar; Borresen-Dale, AL; Børresen-Dale, Anne-Lise; Gram, Inger Torhild; Lillehaug, Johan Richard; Lonning, PE; Lønning, Per Eystein
(2007).
Mutations and polymorphisms of the p21B transcript in breast cancer.
International Journal of Cancer.
Vol. 121.
https://doi.org/10.1002/ijc.22777
